Benitec Biopharma Ownership 2024 | Who Owns Benitec Biopharma Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

23.95%

Insider Ownership

4.86%

Retail Ownership

71.19%

Institutional Holders

1.00

Benitec Biopharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AWM INVESTMENT COMPANY, INC.	23.95%	0.59%	625,000	625,000	100.00%	4,368,750	Jun 30, 2024

Benitec Biopharma's largest institutional shareholder is AWM INVESTMENT COMPANY, INC., holding 23.95% of the company's total share outstanding, currently valued at $4.37M. The top 10 institutional shareholders own together 23.95% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AWM INVESTMENT COMPANY, INC.	23.95%	0.59%	625,000	625,000	100.00%	4,368,750	Jun 30, 2024

The largest Benitec Biopharma shareholder by % of total assets is AWM INVESTMENT COMPANY, INC.. The company owns 625.00K shares of Benitec Biopharma (BNTC), representing 0.59% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AWM INVESTMENT COMPANY, INC.	23.95%	0.59%	625,000	625,000	100.00%	4,368,750	Jun 30, 2024

As of Jun 30 2024, Benitec Biopharma's largest institutional buyer is AWM INVESTMENT COMPANY, INC.. The company purchased 625.00K stocks of BNTC, valued at $4.37M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AWM INVESTMENT COMPANY, INC.	23.95%	0.59%	625,000	625,000	100.00%	4,368,750	Jun 30, 2024

As of Jun 30 2024, Benitec Biopharma's biggest institutional seller is AWM INVESTMENT COMPANY, INC.. The company sold 625.00K shares of BNTC, valued at $4.37M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AWM INVESTMENT COMPANY, INC.	23.95%	0.59%	625,000	625,000	100.00%	4,368,750	Jun 30, 2024

Benitec Biopharma's largest new institutional shareholder by number of shares is AWM INVESTMENT COMPANY, INC., purchased 625.00K shares, valued at $4.37M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Benitec Biopharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FRANKLIN STRATEGIC SERIES	0.73%	6,203,064	-	-	Jan 31, 2024
FRANKLIN STRATEGIC SERIES	0.04%	364,887	-	-	Jan 31, 2024
FIDELITY COMMONWEALTH TRUST	0.00%	11,366	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	47,500	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	74,773	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	9,938	-43	-0.43%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	16,701	-16,701	-50.00%	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	200	-	-	Mar 31, 2023
EQ ADVISORS TRUST	0.00%	1,693	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	17,861	-	-	Mar 31, 2024

Benitec Biopharma's largest mutual fund holder by % of total assets is "FRANKLIN STRATEGIC SERIES", owning 6.20M shares, compromising 0.73% of its total assets.

Benitec Biopharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	1	-
30 Sep, 23	1	-93.75%
30 Jun, 23	16	-20.00%
31 Mar, 23	20	-13.04%
31 Dec, 22	23	15.00%
30 Sep, 22	20	5.26%
30 Jun, 22	19	26.67%
31 Mar, 22	15	15.38%
31 Dec, 21	13	-18.75%
30 Sep, 21	16	6.67%
30 Jun, 21	15	15.38%
31 Mar, 21	13	30.00%
31 Dec, 20	10	66.67%
30 Sep, 20	6	20.00%
30 Jun, 20	5	-

As of 30 Jun 24, 1 institutions are holding Benitec Biopharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	625,000	-
30 Sep, 23	23	-100.00%
30 Jun, 23	11,055,879	-4.96%
31 Mar, 23	11,633,366	-5.48%
31 Dec, 22	12,307,556	-15.85%
30 Sep, 22	14,626,516	992.31%
30 Jun, 22	1,339,039	-15.30%
31 Mar, 22	1,580,856	-0.60%
31 Dec, 21	1,590,420	4.53%
30 Sep, 21	1,521,456	0.83%
30 Jun, 21	1,508,890	332.92%
31 Mar, 21	348,541	2.49%
31 Dec, 20	340,081	440.76%
30 Sep, 20	62,889	47.71%
30 Jun, 20	42,575	-

Benitec Biopharma (BNTC) has 625.00K shares outstanding as of 30 Jun 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	23.95%	-
30 Sep, 23	0.03%	0.00%
30 Jun, 23	39.51%	2.29%
31 Mar, 23	41.58%	2.09%
31 Dec, 22	44.65%	1.59%
30 Sep, 22	53.07%	224.83%
30 Jun, 22	4.86%	14.77%
31 Mar, 22	5.74%	17.23%
31 Dec, 21	5.77%	18.94%
30 Sep, 21	5.52%	18.42%
30 Jun, 21	5.47%	342.34%
31 Mar, 21	1.26%	83.06%
31 Dec, 20	1.23%	2369.68%
30 Sep, 20	0.23%	956.05%
30 Jun, 20	0.15%	-

As of 30 Jun 24, Benitec Biopharma is held by 23.95% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	1	-
30 Sep, 23	-	-100.00%
30 Jun, 23	2	-33.33%
31 Mar, 23	3	-72.73%
31 Dec, 22	11	-15.38%
30 Sep, 22	13	8.33%
30 Jun, 22	12	140.00%
31 Mar, 22	5	25.00%
31 Dec, 21	4	-42.86%
30 Sep, 21	7	-22.22%
30 Jun, 21	9	-18.18%
31 Mar, 21	11	83.33%
31 Dec, 20	6	100.00%
30 Sep, 20	3	-40.00%
30 Jun, 20	5	-

1 institutional shareholders have increased their position in BNTC stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-
30 Sep, 23	1	-66.67%
30 Jun, 23	3	-57.14%
31 Mar, 23	7	16.67%
31 Dec, 22	6	200.00%
30 Sep, 22	2	100.00%
30 Jun, 22	1	-66.67%
31 Mar, 22	3	200.00%
31 Dec, 21	1	-
30 Sep, 21	1	-66.67%
30 Jun, 21	3	200.00%
31 Mar, 21	1	-
31 Dec, 20	1	-
30 Sep, 20	1	-
30 Jun, 20	-	-

- institutional shareholders have reduced their position in BNTC stock as of 30 Jun 24 compared to 1 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	1	-	625,000	-	23.95%	-	1	-	-	-
30 Sep, 23	1	-93.75%	23	-100.00%	0.03%	0.00%	-	-100.00%	1	-66.67%
30 Jun, 23	16	-20.00%	11,055,879	-4.96%	39.51%	2.29%	2	-33.33%	3	-57.14%
31 Mar, 23	20	-13.04%	11,633,366	-5.48%	41.58%	2.09%	3	-72.73%	7	16.67%
31 Dec, 22	23	15.00%	12,307,556	-15.85%	44.65%	1.59%	11	-15.38%	6	200.00%
30 Sep, 22	20	5.26%	14,626,516	992.31%	53.07%	224.83%	13	8.33%	2	100.00%
30 Jun, 22	19	26.67%	1,339,039	-15.30%	4.86%	14.77%	12	140.00%	1	-66.67%
31 Mar, 22	15	15.38%	1,580,856	-0.60%	5.74%	17.23%	5	25.00%	3	200.00%
31 Dec, 21	13	-18.75%	1,590,420	4.53%	5.77%	18.94%	4	-42.86%	1	-
30 Sep, 21	16	6.67%	1,521,456	0.83%	5.52%	18.42%	7	-22.22%	1	-66.67%
30 Jun, 21	15	15.38%	1,508,890	332.92%	5.47%	342.34%	9	-18.18%	3	200.00%
31 Mar, 21	13	30.00%	348,541	2.49%	1.26%	83.06%	11	83.33%	1	-
31 Dec, 20	10	66.67%	340,081	440.76%	1.23%	2369.68%	6	100.00%	1	-
30 Sep, 20	6	20.00%	62,889	47.71%	0.23%	956.05%	3	-40.00%	1	-
30 Jun, 20	5	-	42,575	-	0.15%	-	5	-	-	-

Benitec Biopharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 14, 2023	Boston Megan	director, officer	Executive Director	P-Purchase	Buy	25,907	-	$2.59	25,907
Aug 14, 2023	Boston Megan	director, officer	Executive Director	P-Purchase	Buy	25,907	$3.86	$100.00K	25,907
Aug 14, 2023	BUCHI J KEVIN	director	-	P-Purchase	Buy	51,813	-	$5.18	52,097
Aug 14, 2023	BUCHI J KEVIN	director	-	P-Purchase	Buy	51,813	$3.86	$200.00K	51,813

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 14, 2023	Boston Megan	director, officer	Executive Director	P-Purchase	Buy	25,907	-	$2.59	25,907
Aug 14, 2023	Boston Megan	director, officer	Executive Director	P-Purchase	Buy	25,907	$3.86	$100.00K	25,907
Aug 14, 2023	BUCHI J KEVIN	director	-	P-Purchase	Buy	51,813	-	$5.18	52,097
Aug 14, 2023	BUCHI J KEVIN	director	-	P-Purchase	Buy	51,813	$3.86	$200.00K	51,813

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 08, 2024	Mehta Kishan	director			Buy	-	-	-	-
May 02, 2024	SUVRETTA CAPITAL MANAGEMENT, LLC	10 percent owner	-		Buy	-	-	-	1,470,179
May 02, 2024	SUVRETTA CAPITAL MANAGEMENT, LLC	10 percent owner	-		Buy	-	-	-	221,111
May 02, 2024	SUVRETTA CAPITAL MANAGEMENT, LLC	10 percent owner	-		Buy	588,235	-	$1000.00	-
May 02, 2024	SUVRETTA CAPITAL MANAGEMENT, LLC	10 percent owner	-		Buy	276,353	-	$27.64	-
May 02, 2024	SUVRETTA CAPITAL MANAGEMENT, LLC	10 percent owner	-		Buy	588,236	$1.93	$1.14M	-
May 02, 2024	SUVRETTA CAPITAL MANAGEMENT, LLC	10 percent owner	-		Buy	576,347	$3.86	$2.22M	-
Mar 08, 2024	Banks Jerel A.	director, officer	Chief Executive Officer	A-Award	Buy	466,554	$5.21	$2.43M	466,554
Mar 08, 2024	Boston Megan	director, officer	Executive Director	A-Award	Buy	200,004	$5.21	$1.04M	200,004
Dec 07, 2023	Smith Edward F	director	-	A-Award	Buy	35,000	$3.13	$109.55K	35,000
Dec 07, 2023	Francis Peter	director	-	A-Award	Buy	35,000	$3.13	$109.55K	35,000
Dec 07, 2023	BUCHI J KEVIN	director	-	A-Award	Buy	35,000	$3.13	$109.55K	35,000
Aug 14, 2023	Boston Megan	director, officer	Executive Director	P-Purchase	Buy	25,907	-	$2.59	25,907
Aug 14, 2023	Boston Megan	director, officer	Executive Director	P-Purchase	Buy	25,907	$3.86	$100.00K	25,907
Aug 14, 2023	BUCHI J KEVIN	director	-	P-Purchase	Buy	51,813	-	$5.18	52,097
Aug 14, 2023	BUCHI J KEVIN	director	-	P-Purchase	Buy	51,813	$3.86	$200.00K	51,813
Jun 15, 2023	Boston Megan	director, officer	Executive Director	A-Award	Buy	153,000	$0.23	$35.19K	153,000
Jun 15, 2023	Banks Jerel A.	director, officer	Chief Executive Officer	A-Award	Buy	356,900	$0.23	$82.09K	356,900
Dec 09, 2022	Smith Edward F	director	-	A-Award	Buy	12,000	-	-	12,000
Dec 09, 2022	BUCHI J KEVIN	director	-	A-Award	Buy	12,000	-	-	12,000

The last insider buy of BNTC was made by Boston Megan on Aug 14 2023, buying 25,907 shares at - per share (worth $2.59).

Benitec Biopharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	2	-	-
Q4 2023	3	-	-
Q3 2023	4	-	-
Q2 2023	2	-	-
Q4 2022	3	-	-
Q4 2021	5	-	-
Q2 2021	4	-	-
Q4 2020	6	-	-
Q2 2020	-	9	-

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Benitec Biopharma's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	4	-	-
Q2 2023	-	-	-
Q4 2022	-	-	-
Q4 2021	2	-	-
Q2 2021	4	-	-
Q4 2020	-	-	-
Q2 2020	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Benitec Biopharma's stocks.

Benitec Biopharma Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
ONCR	Oncorus, Inc.
VIRI	Virios Therapeutics, Inc.
NXTC	NextCure, Inc.
APLM	Apollomics, Inc.
BPTH	Bio-Path Holdings, Inc.
CAPR	Capricor Therapeutics, Inc.
DFFN	CervoMed Inc.
LABP	Landos Biopharma, Inc.
SGTX	Sigilon Therapeutics, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
CBIO	Gyre Therapeutics, Inc.
ZURA	Zura Bio Limited
ALRN	Aileron Therapeutics, Inc.

BNTC Ownership FAQ

Who Owns Benitec Biopharma?

Benitec Biopharma is owned by institutional shareholders (23.95%), insiders (4.86%), and public (71.19%). The largest institutional shareholder of Benitec Biopharma is AWM INVESTMENT COMPANY, INC. (23.95% of total shares) and the top mutual fund owner is FRANKLIN STRATEGIC SERIES (0.73% of total shares).

Who are the major institutional shareholders of Benitec Biopharma?

Benitec Biopharma's major institutional shareholders are AWM INVESTMENT COMPANY, INC.. The top five shareholders own together 23.95% of the company's share outstanding.

How many Benitec Biopharma shareholders are there?

As of Jun 2024, there are 1 institutional shareholders of Benitec Biopharma.

What percentage of Benitec Biopharma is owned by AWM INVESTMENT COMPANY, INC?

AWM INVESTMENT COMPANY, INC owns 625K shares of Benitec Biopharma, representing 23.95% of the company's total shares outstanding, valued at $4.37M (as of Jun 2024).